Article Text

Download PDFPDF
Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjögren syndrome: an explanatory interventional study

Statistics from


  • Competing interests: None.

  • Funding: This research was funded by The Health and Medical Care Executive Board of the Västra Götaland, Rune och Ulla Amlövs foundation for Rheumatology Research, Göteborg’s Association Against Rheumatism, Reumaforskningsfond Margareta, The Medical Society of Göteborg, the Medical Faculty of Göteborg (LUA) and Finska Läkaresällskapet, HUS TYH 2235 evo grant, Invalid Foundation, the Finnish Dental Society Apollonia, CIMO and Helsinki University.

  • Ethics approval: Patients gave informed written consent and the study was approved by the local Ethics Committee.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.